MediWound Ltd.

MDWD Nasdaq SEC CIK 1593984
Follow MediWound Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · IFRS
EPS, diluted -
Revenue by quarter
$5.1M
$5.7M
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20M$40MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$17M−$23.9M
FY24$20.2M−$30.2M
FY23$18.7M−$6.7M
FY22$26.5M−$19.6M
FY21$23.8M−$13.6M
FY20$21.8M−$9.2M
FY19$31.8M$5M
FY18$3.4M−$1.1M
FY17$2.5M−$22.1M
FY16$1.6M−$18.9M
FY15$601K−$22.1M
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−4000%−3000%−2000%−1000%0%1000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2519.2%−149%−140.8%
FY2413%−95.9%−149.5%
FY2319.1%−81.8%−35.9%
FY2249.7%−31.5%−74%
FY2136.9%−47.2%−57%
FY2034.7%−40.6%−42.3%
FY1962.7%14.1%15.6%
FY1838.6%−116.4%−31.1%
FY1736.8%−548.4%−887.4%
FY16−38.5%−1293.6%−1212.1%
FY15−319.1%−3531.9%−3675.2%
FY14---
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0$10MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$21.6M
FY24−$19.9M
FY23−$16.9M
FY22−$12.4M
FY21−$9.4M
FY20−$7.8M
FY19$7.5M
FY18−$12.7M
FY17−$17.5M
FY16−$17.1M
FY15−$20M
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • MediWound Ltd.
  • Healthcare median
−4000%−3000%−2000%−1000%0%1000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearMediWound Ltd.Healthcare median
FY25−140.8%−30.6%
FY24−149.5%−47%
FY23−35.9%−58%
FY22−74%−80.4%
FY21−57%−71.9%
FY20−42.3%−62.2%
FY1915.6%−46.3%
FY18−31.1%−49.6%
FY17−887.4%−45.9%
FY16−1212.1%−36%
FY15−3675.2%−38.4%
FY14-−35.5%